Top compounds associated with response to UBD


Feature Type Standardized
Nominal ANOVA
mRNA 968 CTRPv2 pan-cancer AAC -0.041 0.6
mRNA GDC-0941 CTRPv2 pan-cancer AAC 0.02 0.6
mRNA doxorubicin:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.018 0.6
mRNA BRD-K02251932 CTRPv2 pan-cancer AAC -0.021 0.6
mRNA tacrolimus CTRPv2 pan-cancer AAC -0.019 0.6
mRNA VU0155056 CTRPv2 pan-cancer AAC 0.02 0.6
mRNA KU-0063794 CTRPv2 pan-cancer AAC 0.019 0.6
mRNA selumetinib:PLX-4032 (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.019 0.6
mRNA ML050 CTRPv2 pan-cancer AAC -0.02 0.6
mRNA selumetinib:GDC-0941 (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.019 0.6
Download CSV